🇺🇸 FDA
Patent

US 7393544

Dispersion for pulmonary delivery of a bioactive agent

granted A61KA61K31/685A61K9/0073

Quick answer

US patent 7393544 (Dispersion for pulmonary delivery of a bioactive agent) held by Nektar Therapeutics expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/685, A61K9/0073, A61K9/0075, A61K9/0078